CTRI/2024/09/073884尚未招募3 期
A Clinical Study to Evaluate The Efficacy of Bibhitakadi Kwatha & Avalgujadi Lepa in The Management of Shwitra (Vitiligo)
Dr.Sarvepalli Radhakrishnan Rajasthan Ayurved Univetrsity ,Jodhpur1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年10月1日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- The primary outcome of the clinical study evaluating the efficacy of Bibhitakadi Kwatha and Avalgujadi Lepa in the management of Shwitra (Vitiligo).
研究概览
简要总结
It is a randomized, prospective, open-label, interventional comparative clinical trial. The trial consists of three groups: one will receive Bibhitakadi Kwatha ,the second group will receive Avalgujadi Lepa, and the third group will receive both Bibhitakadi Kwatha and Avalgujadi Lepa together.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients with signs and symptoms of Shwitra Roga, specifically skin depigmentation (Twak Vaivarnya), will be selected for this study. This includes individuals exhibiting the classical signs and symptoms of Shwitra, regardless of sex, aged between 18 and 60 years. Participants must be willing to sign the consent form, take the prescribed medicine properly, adhere to dietary and lifestyle guidelines (Pathya.
- •Apathya), and be cooperative in following all study instructions.
排除标准
- •Participants will be excluded if they have severe skin disorders, chronic systemic diseases, sexually transmitted diseases, uncontrolled diabetes mellitus, blood-related disorders, or organ failure.
- •Other exclusions include those on medication for the same illness, unwilling participants, patients with leprosy, albinism, pregnant or lactating women, patches from trauma, burns, or chemical exposure, long-term steroid or cytotoxic treatment, adverse reactions to treatment, and malignancy.
结局指标
主要结局
The primary outcome of the clinical study evaluating the efficacy of Bibhitakadi Kwatha and Avalgujadi Lepa in the management of Shwitra (Vitiligo).
时间窗: Total study time 90 days | Follow up at every 2 weeks
次要结局
- Bibhitakadi Kwatha & Avalgujadi Lepa will provide a safe & effective treatment.
研究者
Ayushi Bhaskar
Madan Mohan Malviya govt ayurved college udaipur
研究点 (1)
Loading locations...
相似试验
尚未招募
3 期
Comparing Anubhoota Yoga and Jatyadi Taila for Healing Dushta Vrana Chronic Wounds in Patients.CTRI/2025/03/082338Dr Sailash M40
尚未招募
2 期
Efficacy and Safety BerBerista in the management of ObesityCTRI/2025/10/096067M R HEALTHCARE PVT LTD20
招募中
3 期
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With RisdiplamSpinal Muscular AtrophyNCT07444476Biogen90
尚未招募
3 期
To Study Efficacy of the Bibhitaka Pratisarniya Kshara in the treatment of PilesCTRI/2025/01/079713Dr Priyanka Parmeshwar Garje70
尚未招募
不适用
A Phase II Study of Toripalimab Plus RC48-ADC With Radiotherapy for Bladder Preservation in HER2-Positive Muscle-Invasive Bladder CancerNCT07279597Tongji Hospital45